A literature study on oncological Immune therapy

암(癌)의 면역치료(免疫治療)에 대(對)한 고찰(考察)

  • Park, Jong-Hak (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Son, Chang-Gyu (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Cho, Chong-kwan (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daejeon University)
  • 박종학 (대전대학교 한의과대학 간계내과학교실) ;
  • 손창규 (대전대학교 한의과대학 간계내과학교실) ;
  • 조종관 (대전대학교 한의과대학 간계내과학교실)
  • Published : 2001.02.26

Abstract

A literature study on oncological immune therapy was done, and the results were as follows. 1. Oncological immune therapy is classified as specific non specific therapy or active inactive therapy, and in tumor immune response, cellular immunity operates mainly, so activity of T lymphocytes and macrophages are closely related with growth, progress, metastasis and prospect of tumor. Recently, Immune therapies of gene which use cytokines and HLA-B7 are carrying out. 2. In oriental medicine, development of disease is closely related to up and down of healthy qi, so healthy qi operates as a immune factor and resistance factor. 3. On the base of theory "Increasing healthy qi reduces mass(養正則積自除)", strengthening body resistance is emphasized in cancer therapy. Also strengthening body resistance activates cellular immune response and promote killing tumor facility of T-cell. 4. In clinical view, using immune therapy after operation, radiation, and chemotheraphy is more effective than immune therapy itself, so it is expected that east-west cooperation will be effective in cancer therapy. 5. The study of oncological immunity is progressed on emphasizing T-cell and it is related to oriental medical theory "strengthening healthy qi to eliminate pathogen(扶定祛邪)" and advanced study is expected in future.

Keywords